Myeloid Neoplasia Panel (141 Genes)
| TEST CODE | MGG0040 |
| TEST NAME | Myeloid Neoplasia Panel (141 Genes) |
| RELATED GENE | PRAMEF2, PTEN, RELN, SMARCB1, ANKRD26, ASXL1, BCOR, BCORL1, BIRC3, C17orf97, CARD11, CBLC, CEBPA, CHEK2, CSF1R, DAXX, DDX41, DNMT1, ELANE, FLRT2, FLT3, GATA1, IDH1, IDH2, IKZF1, JAK1, JAK3, KIT, KMT2A, KRAS, MPL, MYC, NBN, NPM1, NRAS, NSD1, OR13H1, OR8B12, P2RY2, PCDHB1, PHF6, PRPF8, PTPN11, RAD21, RUNX1, SF1, SF3A1, SMC1A, SMC3, SRP72, SRSF2, STAG2, STXBP2, U2AF1, U2AF2, WT1, ADA, BLM, KCNA4, KLHL6, NPAT, TAL1, TERT, TUBA3C, WAS, WRN, ABL1, RB1, TP53, LUC7L2, BCL6, BCR, GJB3, SH2D1A, ATRX, ETNK1, GNAS, SETBP1, XPO1, ZRSR2, CBL, CBLB, DNMT3A, EED, ETV6, EZH2, PRPF40B, SUZ12, TET2, JAK2, KAT6A, NF1, SF3B1, SH2B3, KLHDC8B, TPMT, BRCA1, BRCA2, BRINP3, CUX1, FAM47A, FAS, KCNK13, MYD88, PML, PRF1, SAXO2, STAT3, TERC, TNFRSF13B |
| SYNONYMOUS | PRAMEF2, PTEN, RELN, SMARCB1, ANKRD26, ASXL1, BCOR, BCORL1, BIRC3, C17orf97, CARD11, CBLC, CEBPA, CHEK2, CSF1R, DAXX, DDX41, DNMT1, ELANE, FLRT2, FLT3, GATA1, IDH1, IDH2, IKZF1, JAK1, JAK3, KIT, KMT2A, KRAS, MPL, MYC, NBN, NPM1, NRAS, NSD1, OR13H1, OR8B12, P2RY2, PCDHB1, PHF6, PRPF8, PTPN11, RAD21, RUNX1, SF1, SF3A1, SMC1A, SMC3, SRP72, SRSF2, STAG2, STXBP2, U2AF1, U2AF2, WT1, ADA, BLM, KCNA4, KLHL6, NPAT, TAL1, TERT, TUBA3C, WAS, WRN, ABL1, RB1, TP53, LUC7L2, BCL6, BCR, GJB3, SH2D1A, ATRX, ETNK1, GNAS, SETBP1, XPO1, ZRSR2, CBL, CBLB, DNMT3A, EED, ETV6, EZH2, PRPF40B, SUZ12, TET2, JAK2, KAT6A, NF1, SF3B1, SH2B3, KLHDC8B, TPMT, BRCA1, BRCA2, BRINP3, CUX1, FAM47A, FAS, KCNK13, MYD88, PML, PRF1, SAXO2, STAT3, TERC, TNFRSF13B |
| OMIM | |
| HEREDITY | |
| CLINICAL AREA | Genetic tests performed on cancer patients and their relatives can provide vital results as they have a guiding effect on diagnosis and potential treatment applications. Within the scope of the Myeloid Neoplasia Panel, genetic variants associated with myeloid leukemia are identified in 141 genes, supporting diagnosis and prognosis as well as the treatment process. |
| METHOD | Next Generation Sequencing |
| SAMPLE TYPE | Blood with EDTA / Bone Marrow / /Paraffin Block / Liquid Biopsy |
| QUANTITY | 3 mL |
| TAT | 21 DAYS |
ORDER OPTIONS AND PRICING
Discover genetic insights at your convenience. Contact Mikrogen anytime for information on order options, pricing, and comprehensive genetic testing services